We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Will you develop an algorithm that beats cancer?

Will you develop an algorithm that beats cancer?

Learn how we’re leveraging data and technology to advance science and fight disease.